Financial Services
Loan book growth is strong. Balances are up across products, and on paper the institution looks stronger than it did a year ago.
Then finance is asked what that growth actually did to risk-adjusted return, and the honest answer takes longer to reach than it should. Funding cost has moved.
Credit losses vary by product and vintage in ways not always reconciled with pricing. Whether growth is building durable earnings, or simply adding balance at a return leadership hasn't fully priced, isn't something that can currently be answered with confidence.
Loan balances are climbing, with no reliable decomposition of what that means for risk-adjusted return by product
Credit loss trends are tracked, but not always reconciled consistently against pricing, funding cost, capital, and operating cost in one product-level view
Funding cost by product line shifts with rate and liquidity conditions, but its effect on margin isn't always isolated from other drivers
Risk-adjusted return figures for the board arrive later than the growth figures they're meant to explain
What's Actually Breaking
Balance, pricing, funding cost, credit losses, and capital consumption sit across core banking, treasury, risk platforms, and finance. Assembling them into one view of what a product actually returns, after funding and risk, is not always done consistently.
Credit losses are tracked, often carefully, but the real gap isn't visibility into losses alone, it's that they're not consistently reconciled with pricing, funding cost, capital, and operating cost in one product-level return view. Each piece gets analysed on its own.
Regulatory and economic capital figures by product are often calculated on a cycle slower than the business actually changes, so decisions get made on a capital picture that's already somewhat dated.
Shows balance, pricing, and loss figures clearly, but rarely decomposes margin movement into its actual product-level drivers.
Request a Diagnostic ConversationAddresses risk broadly, without necessarily addressing the specific product, segment, or vintage where risk-adjusted return is actually weakest.
Examine and reconcile each period's margin movement across balance and mix, yield and pricing, funding cost, credit losses, capital consumption, and operating cost, using agreed rules rather than siloed analysis.
This isn't a promise of complete certainty, it's a view of the most material return drivers with a clear flag on where attribution still depends on assumption.
Accountability for improving the weakest inputs is clarified before the next reporting cycle.
Reconcile risk-adjusted return consistently by product, and flag where funding cost, credit loss, or capital consumption outliers are eroding margin before the issue becomes materially significant.
Decide pricing strategy, risk appetite, or capital allocation across products. It can make the economics visible. Those decisions stay with leadership.
Examines financial performance across balance and mix, pricing, funding cost, credit losses, and capital consumption by product. Leadership leaves with a clear view of the most material return drivers, a flagged list of where attribution still relies on assumption, and a prioritised view of what to address first.
Request a Diagnostic ConversationLoan book growth means little if leadership can't trace what happened to the risk-adjusted return behind it.
If your business is growing but reporting, workflows, data, or execution are becoming harder to manage, Kelarix can help you diagnose where better systems can create real leverage.
